Multi-dimensional imaging of endogenous leucine aminopeptidase via fast response fluorescent read-out probe
Dyes and Pigments, ISSN: 0143-7208, Vol: 187, Page: 109145
2021
- 11Citations
- 4Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Abnormal expression of leucine aminopeptidase (LAP) in living system is associated with various diseases. But so far, there is no detailed imaging analysis of LAP distribution in living cells and organisms with fluorescent probes. In this work, we present a fast-response fluorescent read-out probe (NBD-S-Leu) for imaging LAP in living cancer cells and zebrafish models from multi-dimensional. NBD-S-Leu was constructed by incorporating a dipeptide (cysteinyl-leucine: Cys-Leu) into a commercially available fluorescent 4-chloro-7-nitro-2,1,3- benzoxadiazole (NBD-Cl) scaffold with rational design. Upon exposure to LAP, the amide bond in dipeptides will be cleaved, and subsequently, an intramolecular S → N rearrangement will be occurred, resulting in a dramatic fluorescence light-up and realize the chemoselective detection of LAP. The sensing mechanism was fully supported by TD-DFT calculations and HPLC-HRMS analysis. NBD-S-Leu performs well and features excellent water solubility, fast-response (~4 min) to LAP, low cytotoxicity, as well as good tissue-permeable. Furthermore, NBD-S-Leu has been effectively utilized to image endogenous LAP activity in various types of living cells and zebrafish models. Impressively, with the help of 2.5-dimensional (2.5 D) and 3-dimensional (3 D) confocal imaging, the endogenous LAP distribution in different living cells and zebrafish organs were clearly observed from more than one angle for the first time owing to the high signal-to-noise ratio. Collectively, this fluorescent read-out system does not only provide an alternative method for accurate detection of LAP activity but also can help LAP-related pathological analysis in living organisms and screening inhibitors.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0143720821000139; http://dx.doi.org/10.1016/j.dyepig.2021.109145; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85099373878&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/S0143720821000139; https://dx.doi.org/10.1016/j.dyepig.2021.109145
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know